News & Updates

Combining high-dose vitamin D supplementation (VDS) with enuresis alarm (EA) therapy results in significant reductions in wet-night frequency and improves treatment response, satisfaction, and quality of life (QoL) relative to EA alone in children with primary monosymptomatic nocturnal enuresis (PMNE) and serum 25-hydroxyvitamin D (25[OH]D) levels below 30 ng/mL, a study has shown.

A large real-world study presented at ESHRE 2026 shows an association between short sleep duration, sleep apnoea, and poor sperm quality.

For patients with urinary retention requiring clean intermittent catheterization, the use of reusable catheters does not appear to increase the risk of urinary tract infection (UTI) and serious complications when compared with single-use catheters, according to a noninferiority randomized clinical trial.

A microsimulation study conducted by researchers from the University of Hong Kong (HKU), Guangzhou Medical University, and Shanghai Jiao Tong University shows that prostate-specific antigen (PSA) screening would be highly cost-effective and significantly improve survival outcomes for patients with prostate cancer in China.

New drug applications approved by US FDA as of 16-30 June 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Combining toripalimab with gemcitabine and cisplatin chemotherapy is safe and efficacious in patients with muscle-invasive bladder cancer (MIBC), demonstrating its potential as a neoadjuvant treatment (NAT) in a phase II clinical trial.